Igermetostat
Igermetostat is EZH2 inhibitor, used in cancer research in vivo and in vitro[1].
Product Specifications
CAS Number
2409538-60-7
UNSPSC
12352005
Target
Histone Methyltransferase
Type
Reference compound
Related Pathways
Epigenetics
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/igermetostat.html
Solubility
10 mM in DMSO
Smiles
O=C(NCC1=C(C)C=C(C)NC1=O)C2=CC(O[C@H]3C[C@H](N4CCCCC4)C3)=CC(N(CC)C5CCOCC5)=C2C
Molecular Formula
C32H46N4O4
Molecular Weight
550.73
References & Citations
[1]Peng, et al. Polysubstituted benzene compound and preparation method and use thereof. World Intellectual Property Organization, WO2020020374 A1. 2020-01-30.
Shipping Conditions
Room temperature
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
C0013-04L-AP 200 µL
C-Abl, CT (ABL, Tyrosine-protein Kinase ABL1, Abelson Murine Leukemia Viral Oncogene Homolog 1, Proto-oncogene c-Abl, p150, ABL1, JTK7) (AP) discontinued
Sign In for Pricing
View Details K0354203 1.0 µg DNA
CALB2 sgRNA CRISPR Lentivector (Human) (Target 2)
Sign In for Pricing
View Details 